ZEALAND PHARMA A/S
CIK 0001674988
Revenue (TTM)
292.57M
−17.2% YoY
FY Dec 2021
Net Income (TTM)
−1.02B
−20.2% YoY
FY Dec 2021
EPS Diluted (TTM)
−23.75
−7.6% YoY
FY Dec 2021
Gross Margin
59.4%
FY Dec 2021
Operating Margin
-359.7%
FY Dec 2021
Net Margin
-348.0%
FY Dec 2021
Free Cash Flow (TTM)
—
FY Dec 2021
Cash
1.13B
FY Dec 2021
Total Debt
—
FY Dec 2021
Shares Outstanding
—
FY Dec 2021